Matt was born and raised outside of Fort Worth, Texas before attending The University of Texas at Austin. There, he developed a passion for immunology and scientific discovery.
After graduation Matt traded in his burnt orange for maroon, exchanging the blistering Texas summers for bitter Midwest winters. He’s transformed into more and more of an urbanite (stroads are a crime on humanity), but enjoys recharging in nature whenever he can.
After detesting swimming, biking, and running as a child, he now enjoys all three of those triathlon disciplines – proving that people really can change.
B.S. in Biomedical Engineering, The University of Texas at Austin, 2018
Advisor: Prof George Georgiou
“In the middle of winter I at last discovered that there was in me an invincible summer.”
Krutzik, P. O. & Nolan, G. P. Fluorescent cell barcoding in flow cytometry allows high-throughput drug screening and signaling profiling. Nature Methods 3, 361–368 (2006)
If you could be a piece of lab equipment, what would you be?
Matt enjoys exploring fundamental immunological questions while keeping an eye for clinical translations. His research focuses on improving vaccine adjuvants – components that crudely boost the immune response. Specifically, he seeks to improve tolerability and control of adjuvants, asking the question: “do we need to feel sick in order to achieve vaccine protection?”. His project involves high-throughput screening of thousands of small molecule “immunomodulators” that alter traditional adjuvant properties. Ideally, he’ll find combinations that preserve and improve the beneficial aspects of immune activity while decreasing negative side effects like systemic inflammation.
Moser, B. A. et. al. Small Molecule NF-κB Inhibitors as Immune Potentiators for Enhancement of Vaccine Adjuvants. Front. Immunol. 11, (2020).
Moser, B. A. et al. Increased vaccine tolerability and protection via NF-κB modulation. Science Advances 6, eaaz8700 (2020).